Furthermore, HOMA-IR values decreased significantly greater in the NAFLD group (11.5 ± 5.5%) than in the group without NAFLD (0.5 ± 6.1%; p = 0.04) at week 12, while a similar, but non-significant trend for a difference in insulin levels was observed (NAFLD: 7.9 ± 5.2%; no NAFLD: 2.6 ± 5.9%, p = 0.06). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.